Longeveron (LGVN) Accumulated Expenses (2019 - 2026)
Longeveron (LGVN) posted Accumulated Expenses of $2.65 million for Q2 2026, up 39.3% from $1.91 million a year earlier but down 9.2% from the prior quarter.
Powered by 
Analysis
Longeveron (LGVN) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Longeveron's Accumulated Expenses came in at $2.97 million, up 63.1% from FY2024.
- Annual Accumulated Expenses shows a four-year compound annual growth rate of 22.3% (FY2021 to FY2025).
- In prior years, Longeveron's Accumulated Expenses was $1.82 million in FY2024 (-15.4%), $2.15 million in FY2023 (+231.1%), $650,000 in FY2022 (-51.0%) and $1.33 million in FY2021.
- Quarterly Accumulated Expenses has run from a low of $613,000 in Q1 2023 to a high of $3.17 million in Q3 2025 over five years.
- On a year-over-year basis, Accumulated Expenses has increased in each of the last five quarters, with growth averaging 33.3% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2024, with growth of 291.7%; the weakest was Q4 2022, with a decline of 51.0%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $2.92 million (Q1 2026), $2.97 million (Q4 2025) and $3.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Longeveron | 8.60 Mn | -31.21 Mn | 182,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.65 Mn |
| Mar 31, 2026 | 2.92 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 613,000.00 |
| Dec 31, 2022 | 650,000.00 |
| Sep 30, 2022 | 728,000.00 |
| Jun 30, 2022 | 823,000.00 |
| Mar 31, 2022 | 791,000.00 |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 834,000.00 |
API Access
Longeveron Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();